Fluticasone Furoate

糠酸氟替卡松

Report date: 2025/11/14 13:59:06
NME

Base Information

Drug NameFluticasone Furoate
Drug Alias Name艾敏释fluticasonum furoas氟地松furoate de fluticasonefuroato de fluticasona +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, VasomotorRhinitis, Allergic, Seasonal +[9] 
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date2007/04/27
Country/TerritoryCzechiaBelgiumBulgaria +[41] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCGlaxosmithkline PlcGlaxosmithkline (Ireland) Ltd +[5] 
Inactive CompaniesSandozAstrazeneca PlcMerck Sharp & Dohme LLC
Active IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, Allergic, PerennialRhinitis, Allergic +[4] 
Inactive IndicationsRhinitis, VasomotorRhinitis, Allergic, SeasonalPulmonary Disease, Chronic Obstructive +[5] 

Other Information

ATC CodeR01AD12R03BA09
Related LinksWikipediaDrugBankKEGG